Tadalafil Tablet, Film Coated
Product Images NDC 82968-005

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 82968-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fourrts (india) Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tadalafil Tablet Usp 10mg (NDC)

This is a product description for Tadalafil Tablets, 10 mg, manufactured by Fourrts (India) Laboratories Pvt. Ltd. and distributed by Fourrts Pharmaceuticals USA LLC. The tablets come in a pack of 30 and are not recommended to be split. The entire dose should be taken as per the prescribing information. The usual dosage instructions can be found in the accompanying literature. It is advised to store the tablets at 25°C (77°F) with excursions allowed between 15-30°C (59-86°F). The medication should be kept out of reach of children and dispensed in a tight container.*

FDA Label Image

Tadalafil Tablet Usp 20mg (NDC)

This is a description of Tadalafil Tablets, USP manufactured by Fourrts (India) Laboratories Pvt. Ltd. The tablets come in a pack containing 30 Tablets with 20 mg of tadalafil each. It is advised not to split the tablets and the entire dose should be taken. The recommended storage conditions are at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The product is distributed by Fourrts Pharmaceuticals USA LLC, with a mention of Mig. Lic. No.: TNOODO3031. Additionally, it is important to keep the tablets out of reach of children and dispense in a tight container. The usual dosage information can be found in the accompanying literature.*

FDA Label Image

Tadalafil Tablet Usp 5mg (NDC)

This text contains information about Tadalafil Tablets, USP with each tablet containing 5 mg of tadalafil. The tablets are not to be split, and the entire dose should be taken. The usual dosage information is available in accompanying literature. It is manufactured by Fourrts (India) Laboratories Pvt. Ltd. and distributed by Fourrts Pharmaceuticals USA LLC. It also provides details on storage conditions, warnings to keep out of reach of children, and instructions for dispensing in a tight container. The text includes an NDC code for the tablets and mentions a manufacturing and expiration date.*

FDA Label Image

Tadalafil Tablet Usp 2.5mg (NDC 82968-001-03- 15s-Blister Label)

FDA Label Image

Tadalafil Tablet Usp 5mg (NDC)

FDA Label Image

Tadalafil Tablet Usp 2.5mg (NDC 82968-001-03- 30s-carton Label)

This text is a set of instructions for taking Tadalafil Tablets, USP for once daily use. It provides information on dosage, frequency, and how to store the medication. It also includes details about the contents of the box, the amount of tadalafil in each tablet, and a warning to keep the tablets out of reach of children. Additionally, it mentions the manufacturer and distributor of the tablets.*

FDA Label Image

Tadalafil Tablet Usp 5mg (NDC)

This text provides instructions for taking Tadalafil Tablets, USP for once daily use. It mentions that each box contains 2 cards of 15 tablets. The recommended dosage is one tablet daily, with a 5 mg tadalafil content per tablet. It is advised to take the tablet at the same time each day regardless of meals and not to exceed one tablet per day. The storage instructions indicate keeping the medication out of reach of children and storing it at 25°C with excursions permitted to 15-30°C. Additionally, the text includes details about the manufacturer and distributor of the tablets.*

FDA Label Image

Chemical Structure (Tadalafil F001 Structure)

FDA Label Image

Figure (Tadalafil F001)

This text provides data on the difference in blood pressure (mmHg) when using Tadalafil compared to Placebo in both standing and supine positions over time (in hours). The measurements include Standing Systolic BP, Standing Diastolic BP, Supine Systolic BP, and Supine Diastolic BP. It seems to be a comparison study between the effects of Tadalafil and Placebo on blood pressure.*

FDA Label Image

Figure (Tadalafil F002)

This appears to be a medical document with information about different treatments involving Tadalafil, doxazosin, and a placebo. The document includes dosages and the timeline post-dose in hours. The treatment groups seem to be designated by different symbols such as $, GE, and Py. The doses mentioned are 20 mg of Tadalafil combined with 8 mg of doxazosin.*

FDA Label Image

Figure (Tadalafil F003)

This text is providing data on the effects of different drug regimens on systolic blood pressure. It includes measurements at specific times after administration of different treatments, such as tadalafil and doxazosin. The results are presented in a comparison format to evaluate the impact of the medications on blood pressure.*

FDA Label Image

Figure 4 (Tadalafil F004)

The text provides a visualization showing the Plasma Tadalafil Concentration (ug/L) over time for different dosages and administration methods. It compares a single 20-mg tadalafil dose, a single 5-mg tadalafil dose, and a once-daily 5-mg tadalafil dose following 5 consecutive days of administration. The graph measures the concentrations at varying time intervals and indicates how the concentrations change over a 120-hour period. This data can be used to study the pharmacokinetics of tadalafil under different dosing regimens.*

FDA Label Image

Figure 5 (Tadalafil F005)

FDA Label Image

Figure 6 (Tadalafil F006)

FDA Label Image

Figure 7 (Tadalafil F007)

FDA Label Image

Figure 8 (Tadalafil F008)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.